Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on October 4, 2004

Hypertension. 2004
Published online before print October 4, 2004, doi: 10.1161/01.HYP.0000145405.01113.0e
A more recent version of this article appeared on November 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/5/776    most recent
01.HYP.0000145405.01113.0ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Townsend, S. A.
Right arrow Articles by Berkowitz, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Townsend, S. A.
Right arrow Articles by Berkowitz, D. E.
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Receptor pharmacology
Right arrow Other Vascular biology

Submitted on July 20, 2004
Revised on August 2, 2004

Critical Role for the {alpha}-1B Adrenergic Receptor at the Sympathetic Neuroeffector Junction

Seth A. Townsend; Albert S. Jung; Yen Shi Gillian Hoe; Rafael Y. Lefkowitz; Shakil A. Khan; Christoper A. Lemmon; Robert W. Harrison; KwanghHo Lee; Lili A. Barouch; Susanna Cotecchia; Artin A. Shoukas; Daniel Nyhan; Joshua M. Hare; and Dan E. Berkowitz*

From the Departments of Anesthesiology/Critical Care Medicine (K.H.L., D.N., D.E.B.), Medicine (S.A.K., R.W.H., L.A.B., J.M.H.), and Biomedical Engineering (S.A.T., A.S.J., Y.S.G.H., R.Y.L., C.A.L., A.A.S., D.E.B.), Johns Hopkins University School of Medicine, Baltimore, MD; and the University of Lausanne, Switzerland (S.C.).

* To whom correspondence should be addressed. E-mail: dberkowi{at}bme.jhu.edu.

Abstract--The {alpha}-1 adrenergic receptors ({alpha}1ARs) are critical in sympathetically mediated vasoconstriction. The specific role of each {alpha}1AR subtype in regulating vasoconstriction remains highly controversial. Limited pharmacological studies suggest that differential {alpha}1AR responses may be the result of differential activation of junctional versus extrajunctional receptors. We tested the hypothesis that the {alpha}1BAR subtype is critical in mediating sympathetic junctional neurotransmission. We measured in vivo integrated cardiovascular responses to a hypotensive stimulus (induced via transient bilateral carotid occlusion [TBCO]) in {alpha}1BAR knockout (KO) mice and their wild-type (WT) littermates. In WT mice, after dissection of the carotid arteries and denervation of aortic baroreceptor buffering nerves, TBCO produced significant pressor and positive inotropic effects. Both responses were markedly attenuated in {alpha}1BAR KO mice (change systolic blood pressure 46±8 versus 11±2 mm Hg; percentage change in the end-systolic pressure-volume relationship [ESPVR] 36±7% versus 12±2%; WT versus KO; P<0.003). In vitro {alpha}1AR mesenteric microvascular contractile responses to endogenous norepinephrine (NE; elicited by electrical field stimulation 10 Hz) was markedly depressed in {alpha}1BAR KO mice compared with WT (12.4±1.7% versus 21.5±1.2%; P<0.001). In contrast, responses to exogenous NE were similar in {alpha}1BAR KO and WT mice (22.4±7.3% versus 33.4±4.3%; NS). Collectively, these results demonstrate a critical role for the {alpha}1BAR in baroreceptor-mediated adrenergic signaling at the vascular neuroeffector junction. Moreover, {alpha}1BARs modulate inotropic responses to baroreceptor activation. The critical role for {alpha}1BAR in neuroeffector regulation of vascular tone and myocardial contractility has profound clinical implications for designing therapies for orthostatic intolerance.


Key words: receptors, adrenergic alpha • hypotension • sympathetic nervous system • vasoconstriction




This article has been cited by other articles:


Home page
Circ. Res.Home page
L. Santhanam, H. K. Lim, H. K. Lim, V. Miriel, T. Brown, M. Patel, S. Balanson, S. Ryoo, M. Anderson, K. Irani, et al.
Inducible NO Synthase Dependent S-Nitrosylation and Activation of Arginase1 Contribute to Age-Related Endothelial Dysfunction
Circ. Res., September 28, 2007; 101(7): 692 - 702.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. J. Daly, I. McGrath, S. Townsend, and D. E. Berkowitz
The Role of the {alpha}1B-Adrenergic Receptor in Vascular Structure and Function
Hypertension, June 1, 2005; 45(6): e20 - e21.
[Full Text] [PDF]